ArticleEye (London, England)2023

Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study.

Yunxia Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.